Management of Trastuzumab-Related Cardiac Dysfunction-Reference-Cited by-同舟云学术

Management of Trastuzumab-Related Cardiac Dysfunction

Published:2010-09 Issue:2 Volume:53 Page:130-139
ISSN:0033-0620
Container-title:Progress in Cardiovascular Diseases
language:en
Short-container-title:Progress in Cardiovascular Diseases

Author:

Carver Joseph R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference55 articles.

1. Unraveling the biologic and clinical complexities of HER2;Park;Clin Breast Cancer,2008

2. Progressive and predictive value of c-erB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers;Sjogren;J Clin Oncol,1998

3. Human breast cancerL correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

4. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues;Owens;Clin Breast Cancer,2004

5. Her-2/neu expression in node-negative breast cancer: Direct tissue quantification by computerized image analysis and association of overexpression with increased risk of recurrent disease;Press;Cancer Res,1993

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental Model of Cardiotoxicity;Risk Factors for Cardiovascular Disease;2022-04-06

2. Cardiotoxicity after cancer treatment: a process map of the patient treatment journey;Cardio-Oncology;2019-08-22

3. Heart failure following cancer treatment: characteristics, survival and mortality of a linked health data analysis;Internal Medicine Journal;2016-11

5. Risk of Congestive Heart Failure in Early Breast Cancer Patients Undergoing Adjuvant Treatment With Trastuzumab: A Meta-Analysis;The Oncologist;2016-03-29